<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33087517</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>11</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>02</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2379-5042</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>5</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Oct</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>mSphere</Title>
          <ISOAbbreviation>mSphere</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e00637-20</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1128/mSphere.00637-20</ELocationID>
        <Abstract>
          <AbstractText>Guidelines from the CDC and the WHO recommend the wearing of face masks to prevent the spread of coronavirus (CoV) disease 2019 (COVID-19); however, the protective efficiency of such masks against airborne transmission of infectious severe acute respiratory syndrome CoV-2 (SARS-CoV-2) droplets/aerosols is unknown. Here, we developed an airborne transmission simulator of infectious SARS-CoV-2-containing droplets/aerosols produced by human respiration and coughs and assessed the transmissibility of the infectious droplets/aerosols and the ability of various types of face masks to block the transmission. We found that cotton masks, surgical masks, and N95 masks all have a protective effect with respect to the transmission of infective droplets/aerosols of SARS-CoV-2 and that the protective efficiency was higher when masks were worn by a virus spreader. Importantly, medical masks (surgical masks and even N95 masks) were not able to completely block the transmission of virus droplets/aerosols even when completely sealed. Our data will help medical workers understand the proper use and performance of masks and determine whether they need additional equipment to protect themselves from infected patients.<b>IMPORTANCE</b> Airborne simulation experiments showed that cotton masks, surgical masks, and N95 masks provide some protection from the transmission of infective SARS-CoV-2 droplets/aerosols; however, medical masks (surgical masks and even N95 masks) could not completely block the transmission of virus droplets/aerosols even when sealed.</AbstractText>
          <CopyrightInformation>Copyright © 2020 Ueki et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ueki</LastName>
            <ForeName>Hiroshi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Furusawa</LastName>
            <ForeName>Yuri</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iwatsuki-Horimoto</LastName>
            <ForeName>Kiyoko</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">0000-0002-8266-020X</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Imai</LastName>
            <ForeName>Masaki</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kabata</LastName>
            <ForeName>Hiroki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nishimura</LastName>
            <ForeName>Hidekazu</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Research Division, Virus Research Center, National Hospital Organization Sendai Medical Center, Sendai, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kawaoka</LastName>
            <ForeName>Yoshihiro</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">0000-0001-5061-8296</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan yoshihiro.kawaoka@wisc.edu.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>HHSN272201400008C</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>mSphere</MedlineTA>
        <NlmUniqueID>101674533</NlmUniqueID>
        <ISSNLinking>2379-5042</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000336">Aerosols</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>MMW Fortschr Med. 2021 Feb;163(2):10</RefSource>
          <PMID Version="1">33527263</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000336" MajorTopicYN="Y">Aerosols</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000391" MajorTopicYN="Y">Air Microbiology</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
          <QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008397" MajorTopicYN="N">Masks</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
          <QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">COVID-19</Keyword>
        <Keyword MajorTopicYN="Y">N95 masks</Keyword>
        <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
        <Keyword MajorTopicYN="Y">aerosols</Keyword>
        <Keyword MajorTopicYN="Y">droplets</Keyword>
        <Keyword MajorTopicYN="Y">face masks</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>22</Day>
          <Hour>5</Hour>
          <Minute>28</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33087517</ArticleId>
        <ArticleId IdType="pmc">PMC7580955</ArticleId>
        <ArticleId IdType="doi">10.1128/mSphere.00637-20</ArticleId>
        <ArticleId IdType="pii">5/5/e00637-20</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Liu Y, Ning Z, Chen Y, Guo M, Liu Y, Gali NK, Sun L, Duan Y, Cai J, Westerdahl D, Liu X, Xu K, Ho K-F, Kan H, Fu Q, Lan K. 2020. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature
582:557–560. doi:10.1038/s41586-020-2271-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-020-2271-3</ArticleId>
            <ArticleId IdType="pubmed">32340022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishimura H, Sakata S and Kaga A. 2013. A new methodology for studying dynamics of aerosol particles in sneeze and cough using a digital high-vision, high-speed video system and vector analyses. PLoS One
8:e80244. doi:10.1371/journal.pone.0080244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0080244</ArticleId>
            <ArticleId IdType="pmc">PMC3842286</ArticleId>
            <ArticleId IdType="pubmed">24312206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berg EB, Picard RJ. 2009. In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patterns. Respir Care
54:1671–1678.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19961633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q, Song T, He J, Yen H-L, Peiris M, Wu J. 2020. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med
382:1177–1179. doi:10.1056/NEJMc2001737.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc2001737</ArticleId>
            <ArticleId IdType="pmc">PMC7121626</ArticleId>
            <ArticleId IdType="pubmed">32074444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kormuth KA, Lin K, Prussin AJ, Vejerano EP, Tiwari AJ, Cox SS, Myerburg MM, Lakdawala SS, Marr LC. 2018. Influenza virus infectivity is retained in aerosols and droplets independent of relative humidity. J Infect Dis
218:739–747. doi:10.1093/infdis/jiy221.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiy221</ArticleId>
            <ArticleId IdType="pmc">PMC6057527</ArticleId>
            <ArticleId IdType="pubmed">29878137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smither SJ, Eastaugh LS, Findlay JS, Lever MS. 2020. Experimental aerosol survival of SARS-CoV-2 in artificial saliva and tissue culture media at medium and high humidity. Emerg Microbes Infect
9:1415–1417. doi:10.1080/22221751.2020.1777906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/22221751.2020.1777906</ArticleId>
            <ArticleId IdType="pmc">PMC7473326</ArticleId>
            <ArticleId IdType="pubmed">32496967</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
